{"disease":{"id":"whooping-cough","name":"whooping cough"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06258057","title":"Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":365000,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT03463577","title":"The Safety of Boostrix Following Routine Immunization of Pregnant Women","phase":"","overall_status":"COMPLETED","enrollment_count":65783,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT07444502","title":"Safety Monitoring of Boostagen® Vaccine in Thailand","phase":"","overall_status":"COMPLETED","enrollment_count":10727,"lead_sponsor_name":"BioNet-Asia Co., Ltd.","has_results":false},{"nct_id":"NCT07400120","title":"Safety Monitoring of VacPertagen Vaccine in Thailand","phase":"","overall_status":"COMPLETED","enrollment_count":5414,"lead_sponsor_name":"BioNet-Asia Co., Ltd.","has_results":false},{"nct_id":"NCT02983487","title":"Pertussis Immunization Programs in Low Income Countries","phase":"","overall_status":"COMPLETED","enrollment_count":3587,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT05091619","title":"A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2898,"lead_sponsor_name":"China National Biotec Group Company Limited","has_results":false},{"nct_id":"NCT06888076","title":"Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Pregnant Women","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2700,"lead_sponsor_name":"BioNet-Asia Co., Ltd.","has_results":false},{"nct_id":"NCT02587520","title":"Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":1363,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT04807712","title":"Pediatric Pertussis in Ambulatory Settings","phase":"","overall_status":"RECRUITING","enrollment_count":898,"lead_sponsor_name":"Association Clinique Thérapeutique Infantile du val de Marne","has_results":false},{"nct_id":"NCT03388034","title":"Pertussis Immunization Programs in Low Income Countries - Ivory Coast","phase":"","overall_status":"COMPLETED","enrollment_count":789,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT06640387","title":"CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"The Hospital for Sick Children","has_results":false},{"nct_id":"NCT05040802","title":"Effectiveness of Adacel Vaccination in Pregnancy at Preventing Pertussis in Infants < 2 Months of Age in the United States","phase":"","overall_status":"COMPLETED","enrollment_count":462,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT05116241","title":"Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":368,"lead_sponsor_name":"ILiAD Biotechnologies","has_results":true},{"nct_id":"NCT03942406","title":"Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"ILiAD Biotechnologies","has_results":true},{"nct_id":"NCT07213089","title":"Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":290,"lead_sponsor_name":"BioNet-Asia Co., Ltd.","has_results":false},{"nct_id":"NCT03973905","title":"Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States","phase":"","overall_status":"COMPLETED","enrollment_count":290,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03197597","title":"EUpertstrain 4 Study of Bordetella Pertussis Isolates","phase":"","overall_status":"COMPLETED","enrollment_count":265,"lead_sponsor_name":"University of Turku","has_results":false},{"nct_id":"NCT05234229","title":"Influenza and Pertussis Vaccination Status of Women in Immediate Postpartum and Caregivers","phase":"","overall_status":"COMPLETED","enrollment_count":254,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT05897879","title":"Impact of Bacterial Expression and Immune Response in the Severity of Pertussis","phase":"NA","overall_status":"RECRUITING","enrollment_count":210,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT04678271","title":"Assessment, Feedback, Incentive, Exchange (AFIX OB) A Customizable Quality Improvement Intervention to Increase Maternal Vaccine Uptake","phase":"NA","overall_status":"COMPLETED","enrollment_count":202,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT03035370","title":"Viaskin Pertussis Vaccine Trial","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"DBV Technologies","has_results":false},{"nct_id":"NCT07492303","title":"A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":96,"lead_sponsor_name":"Changchun BCHT Biotechnology Co.","has_results":false},{"nct_id":"NCT06466629","title":"The Optimal Timing of Vaccination in Pregnancy","phase":"","overall_status":"RECRUITING","enrollment_count":96,"lead_sponsor_name":"Elke Leuridan, MD, PhD","has_results":false},{"nct_id":"NCT03147898","title":"Observational Study Describing the Immune Profile Induced By Pertussis Vaccines","phase":"","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT03751514","title":"Bordetella Pertussis Colonisation Challenge Study","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"University of Southampton","has_results":false},{"nct_id":"NCT05847322","title":"Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks","phase":"NA","overall_status":"RECRUITING","enrollment_count":72,"lead_sponsor_name":"University of Southampton","has_results":false},{"nct_id":"NCT03578120","title":"Immunising Mums Against Pertussis 3","phase":"","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"St George's, University of London","has_results":false},{"nct_id":"NCT06827470","title":"Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Dalhousie University","has_results":false},{"nct_id":"NCT05461131","title":"Pertussis Challenge Study in Adults Vaccinated With BPZE1","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"ILiAD Biotechnologies","has_results":true},{"nct_id":"NCT04036526","title":"A Phase 1/2 Clinical Trial of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","has_results":false},{"nct_id":"NCT03137927","title":"A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation","has_results":false}],"total":31},"guidelines":[],"source":"Drug Landscape verified database"}